Literature DB >> 29088362

Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.

Kai Zhou1, Wei Yu1, Xiaoli Cao2, Ping Shen1, Haifeng Lu1, Qixia Luo1, John W A Rossen3, Yonghong Xiao1.   

Abstract

OBJECTIVES: To investigate the population structure, drug resistance mechanisms and plasmids of community-associated Enterobacter cloacae complex (CA-ECC) isolates in China.
METHODS: Sixty-two CA-ECC isolates collected from 31 hospitals across China were typed by hsp60 typing and MLST. ESBL and AmpC-overexpression phenotype was determined by double-disc synergy test. Replicon typing and conjugation were performed for plasmid analysis. All ESBL-positive isolates and representative conjugants were subjected to detailed characterization by WGS.
RESULTS: Enterobacter hormaechei and Enterobacter kobei were predominant in our collections. MLST distinguished 46 STs with a polyclonal structure. ST591 was the most prevalent clone detected in northern China. Twenty-two isolates (35.5%) were ESBL positive and half of them were E. kobei. ESBL positivity was related to ESBL production (15/22) and to AmpC overexpression (18/22). Core-genome phylogenetic analysis identified intra- and inter-regional dissemination of ESBL-producing E. kobei clones. ESBL producers were exclusively classified as E. hormaechei and E. kobei, and blaCTX-M-3 was the most prevalent ESBL genotype (10/15) detected in four different environments. In the ESBL-positive population, the ESBL producers encoded more drug resistance genes (8-24 genes) by carrying more plasmids (1-3 plasmids) than the non-ESBL-producing isolates, resulting in an inter-group difference in drug susceptibilities. IncHI-type plasmids were prevalent in the ESBL producers (12/15). All IncHI2-type plasmids (n = 11) carried ESBL genes and shared a similar backbone to p09-036813-1A_261 recovered from Salmonella enterica in Canada.
CONCLUSIONS: The species-specific distribution, species-dependent ESBL mechanism and endemic plasmids identified in our study highlight the necessity for tailored surveillance of CA-ECC in the future.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29088362     DOI: 10.1093/jac/dkx361

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Studies on the Transmission of a Tigecycline Resistance-Mediating tet(A) Gene Variant from Enterobacter hormaechei via a Two-Step Recombination Process.

Authors:  Runhao Yu; Zheng Chen; Danyang Li; Stefan Schwarz; Xinwei Wang; Xiang-Dang Du
Journal:  Microbiol Spectr       Date:  2022-05-17

2.  Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-Producing Enterobacter hormaechei in China.

Authors:  Chunlei Chen; Hao Xu; Ruishan Liu; Xinjun Hu; Jianfeng Han; Lingjiao Wu; Hao Fu; Beiwen Zheng; Yonghong Xiao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-06       Impact factor: 6.073

3.  Genomic epidemiology, antimicrobial resistance and virulence factors of Enterobacter cloacae complex causing potential community-onset bloodstream infections in a tertiary care hospital of Nepal.

Authors:  Sulochana Manandhar; Quynh Nguyen; To Nguyen Thi Nguyen; Duy Thanh Pham; Maia A Rabaa; Sabina Dongol; Buddha Basnyat; Sameer M Dixit; Stephen Baker; Abhilasha Karkey
Journal:  JAC Antimicrob Resist       Date:  2022-05-30

4.  National Prevalence of Salmonella enterica Serotype Kentucky ST198 with High-Level Resistance to Ciprofloxacin and Extended-Spectrum Cephalosporins in China, 2013 to 2017.

Authors:  Honghu Chen; Jingjie Song; Xianying Zeng; Dandan Chen; Rongchang Chen; Chen Qiu; Kai Zhou
Journal:  mSystems       Date:  2021-01-12       Impact factor: 6.496

5.  Frequent convergence of mcr-9 and carbapenemase genes in Enterobacter cloacae complex driven by epidemic plasmids and host incompatibility.

Authors:  Tingting Xu; Chun-Xu Xue; Yuxin Chen; Junxi Huang; Weiyuan Wu; Yuemei Lu; Qiuhui Huang; Dandan Chen; Kai Zhou
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

6.  Colistin Susceptibility in Companion Animal-Derived Escherichia coli, Klebsiella spp., and Enterobacter spp. in Japan: Frequent Isolation of Colistin-Resistant Enterobacter cloacae Complex.

Authors:  Toyotaka Sato; Kazuki Harada; Masaru Usui; Shin-Ichi Yokota; Motohiro Horiuchi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-06       Impact factor: 6.073

7.  Development of a One-Step Multiplex PCR Assay for Differential Detection of Four species (Enterobacter cloacae, Enterobacter hormaechei, Enterobacter roggenkampii, and Enterobacter kobei) Belonging to Enterobacter cloacae Complex With Clinical Significance.

Authors:  Yang Ji; Peihong Wang; Tingting Xu; Yanzi Zhou; Rongchang Chen; Huaiqiu Zhu; Kai Zhou
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

8.  CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales.

Authors:  Amy J Mathers; James S Lewis
Journal:  JAC Antimicrob Resist       Date:  2021-05-07

9.  Wide Distribution and Specific Resistance Pattern to Third-Generation Cephalosporins of Enterobacter cloacae Complex Members in Humans and in the Environment in Guadeloupe (French West Indies).

Authors:  Matthieu Pot; Yann Reynaud; David Couvin; Célia Ducat; Séverine Ferdinand; François Gravey; Gaëlle Gruel; François Guérin; Edith Malpote; Sébastien Breurec; Antoine Talarmin; Stéphanie Guyomard-Rabenirina
Journal:  Front Microbiol       Date:  2021-06-25       Impact factor: 5.640

10.  Carbapenem-Resistant Enterobacter hormaechei ST1103 with IMP-26 Carbapenemase and ESBL Gene bla SHV-178.

Authors:  Jian-Jun Gou; Na Liu; Li-Hua Guo; Hao Xu; Tao Lv; Xiao Yu; Yun-Bo Chen; Xiao-Bing Guo; Yu-Ting Rao; Bei-Wen Zheng
Journal:  Infect Drug Resist       Date:  2020-02-20       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.